Also called: Pulmonary emphysema
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Emphysema
Emphysema is a type of COPD (chronic obstructive pulmonary disease). COPD is a group of lung diseases that make it hard to breathe and get worse over time. The other main type of COPD is chronic bronchitis. Most people with COPD have both emphysema and chronic bronchitis, but how severe each type is can be different from person to person.
Emphysema affects the air sacs in your lungs. Normally, these sacs are elastic or stretchy. When you breathe in, each air sac fills up with air, like a small balloon. When you breathe out, the air sacs deflate, and the air goes out.
In emphysema, the walls between many of the air sacs in the lungs are damaged. This causes the air sacs to lose their shape and become floppy. The damage also can destroy the walls of the air sacs, leading to fewer and larger air sacs instead of many tiny ones. This makes it harder for your lungs to move oxygen in and carbon dioxide out of your body.
The cause of emphysema is usually long-term exposure to irritants that damage your lungs and the airways. In the United States, cigarette smoke is the main cause. Pipe, cigar, and other types of tobacco smoke can also cause emphysema, especially if you inhale them.
Exposure to other inhaled irritants can contribute to emphysema. These include secondhand smoke, air pollution, and chemical fumes or dusts from the environment or workplace.
Rarely, a genetic condition called alpha-1 antitrypsin deficiency can play a role in causing emphysema.
The risk factors for emphysema include:
- Smoking. This the main risk factor. Up to 75% of people who have emphysema smoke or used to smoke.
- Long-term exposure to other lung irritants, such as secondhand smoke, air pollution, and chemical fumes and dusts from the environment or workplace.
- Age. Most people who have emphysema are at least 40 years old when their symptoms begin.
- Genetics. This includes alpha-1 antitrypsin deficiency, which is a genetic condition. Also, smokers who get emphysema are more likely to get it if they have a family history of COPD.
At first, you may have no symptoms or only mild symptoms. As the disease gets worse, your symptoms usually become more severe. They can include:
- Frequent coughing or wheezing
- A cough that produces a lot mucus
- Shortness of breath, especially with physical activity
- A whistling or squeaky sound when you breathe
- Tightness in your chest
Some people with emphysema get frequent respiratory infections such as colds and the flu. In severe cases, emphysema can cause weight loss, weakness in your lower muscles, and swelling in your ankles, feet, or legs.
Your health care provider may use many tools to make a diagnosis:
- A medical history, which includes asking about your symptoms
- A family history
- Other tests, such as lung function tests, a chest x-ray or CT scan, and blood tests
There is no cure for emphysema. However, treatments can help with symptoms, slow the progress of the disease, and improve your ability to stay active. There are also treatments to prevent or treat complications of the disease. Treatments include:
- Lifestyle changes, such as Quitting smoking if you are a smoker. This is the most important step you can take to treat emphysema.
- Avoiding secondhand smoke and places where you might breathe in other lung irritants
- Ask your health care provider for an eating plan that will meet your nutritional needs. Also ask about how much physical activity you can do. Physical activity can strengthen the muscles that help you breathe and improve your overall wellness.
- Bronchodilators, which relax the muscles around your airways. This helps open your airways and makes breathing easier. Most bronchodilators are taken through an inhaler. In more severe cases, the inhaler may also contain steroids to reduce inflammation.
- Vaccines for the flu and pneumococcal pneumonia, since people with emphysema are at higher risk for serious problems from these diseases
- Antibiotics if you get a bacterial or viral lung infection
- An exercise program
- Disease management training
- Nutritional counseling
- Psychological counseling
- Remove damaged lung tissue
- Remove large air spaces (bullae) that can form when air sacs are destroyed. The bullae can interfere with breathing.
- Do a lung transplant. This is might be an option if you have very severe emphysema.
If you have emphysema, it's important to know when and where to get help for your symptoms. You should get emergency care if you have severe symptoms, such as trouble catching your breath or talking. Call your health care provider if your symptoms are getting worse or if you have signs of an infection, such as a fever.
Since smoking causes most cases of emphysema, the best way to prevent it is to not smoke. It's also important to try to avoid lung irritants such as secondhand smoke, air pollution, chemical fumes, and dusts.
It sits within Lungs and Breathing.
The lead U.S. institute for this subject is the National Heart, Lung, and Blood Institute.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Emphysema
553 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Unilateral vs. Bilateral Lung Volume Reduction SurgeryRigshospitalet, Denmark
- A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver ProblemsTakeda
- A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)AIRNA Corporation
- A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPDUpstream Bio Inc.
- Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Secondary to Alpha-1-anti-tripsin DeficiencyUniversity Hospital, Bordeaux
- Role of Genetic Factors in the Development of Lung DiseaseNational Heart, Lung, and Blood Institute (NHLBI)
Research already completed
- Multi-Reader Retrospective Study Examining Carebot AI CXR 2.0.21-v2.01 Implementation in Everyday Radiology Clinical PracticeCarebot s.r.o.
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Diagnosis and Tests
- Alpha-1 Antitrypsin TestingNational Library of Medicine
- Lung Function TestsNational Library of Medicine
- SpirometryMayo Foundation for Medical Education and Research
- SpirometryAmerican Lung Association
Treatments and Therapies
- Lung TransplantMayo Foundation for Medical Education and Research
- Surgery for COPDAmerican Lung Association
Living With
- Oxygen Therapy: MedlinePlus Health TopicNational Library of Medicine
- Pulmonary Rehabilitation: MedlinePlus Health TopicNational Library of Medicine
Related Issues
- Hyperinflated Lungs: What Does It Mean?Mayo Foundation for Medical Education and Research
Genetics
- Alpha-1 antitrypsin deficiency: MedlinePlus GeneticsNational Library of Medicine
Statistics and Research
- FastStats: Chronic Obstructive Pulmonary Disease (COPD) Includes: Chronic Bronchitis and EmphysemaNational Center for Health Statistics
Clinical Trials
- ClinicalTrials.gov: EmphysemaNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Pulmonary Emphysema, Emphysema. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Emphysema, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.